79 related articles for article (PubMed ID: 14587303)
41. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
Klingbeil AU; John S; Schneider MP; Jacobi J; Weidinger G; Schmieder RE
J Hypertens; 2002 Dec; 20(12):2423-8. PubMed ID: 12473867
[TBL] [Abstract][Full Text] [Related]
42. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
[TBL] [Abstract][Full Text] [Related]
43. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
44. Effects of valsartan and hydrochlorothiazide alone and in combination on blood pressure and heart rate in conscious-telemetered spontaneously hypertensive rats (SHR).
Webb RL; Navarrete AE; Davis S
Am J Hypertens; 1998 Jan; 11(1 Pt 1):59-65. PubMed ID: 9504451
[TBL] [Abstract][Full Text] [Related]
45. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial.
Conen D; Everett BM; Glynn RJ; Ridker PM
Heart; 2008 Mar; 94(3):e13. PubMed ID: 17923463
[TBL] [Abstract][Full Text] [Related]
46. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
47. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
Chao CL; Lin YH; Lin LC; Lin LY; Tsai CT; Wang YC; Hwang JJ; Chen JC; Chiang FT
J Int Med Res; 2009; 37(2):289-97. PubMed ID: 19383221
[TBL] [Abstract][Full Text] [Related]
49. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
Yarows SA; Oparil S; Patel S; Fang H; Zhang J
Adv Ther; 2008 Dec; 25(12):1288-302. PubMed ID: 19066757
[TBL] [Abstract][Full Text] [Related]
50. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
Ke YN; Huang J; Zhu JR;
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
[TBL] [Abstract][Full Text] [Related]
51. Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
Ridker PM; Danielson E; Rifai N; Glynn RJ;
Hypertension; 2006 Jul; 48(1):73-9. PubMed ID: 16714425
[TBL] [Abstract][Full Text] [Related]
52. Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension.
Lai WT; Park JE; Dongre N; Wang J
Adv Ther; 2011 May; 28(5):427-38. PubMed ID: 21491172
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy.
Schunkert H; Glazer RD; Wernsing M; Yen J; Macarie CE; Vintila MM; Romanova J
Curr Med Res Opin; 2009 Nov; 25(11):2655-62. PubMed ID: 19751115
[TBL] [Abstract][Full Text] [Related]
54. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
56. Home and clinic blood pressure responses in elderly individuals with systolic hypertension.
Cushman WC; Duprez DA; Weintraub HS; Purkayastha D; Zappe D; Samuel R; Izzo JL
J Am Soc Hypertens; 2012; 6(3):210-8. PubMed ID: 22520932
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V
J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
[TBL] [Abstract][Full Text] [Related]
58. Influence of Age and Race on 24-Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice.
Izzo JL; Jia Y; Zappe DH
J Clin Hypertens (Greenwich); 2017 Feb; 19(2):143-150. PubMed ID: 27587277
[TBL] [Abstract][Full Text] [Related]
59. Canadian valsartan study in patients with mild-to-moderate hypertension.
Lasko BH; Laplante A; Hébert D; Bonnefis-Boyer S
Blood Press Monit; 2001 Apr; 6(2):91-9. PubMed ID: 11433130
[TBL] [Abstract][Full Text] [Related]
60. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
Zappe DH; Sowers JR; Hsueh WA; Haffner SM; Deedwania PC; Fonseca VA; Keeling L; Sica DA
J Clin Hypertens (Greenwich); 2008 Dec; 10(12):894-903. PubMed ID: 19120715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
